1. Home
  2. ASMB vs STIM Comparison

ASMB vs STIM Comparison

Compare ASMB & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$33.80

Market Cap

553.6M

Sector

Health Care

ML Signal

HOLD

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$1.43

Market Cap

105.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASMB
STIM
Founded
2005
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
553.6M
105.5M
IPO Year
2010
2018

Fundamental Metrics

Financial Performance
Metric
ASMB
STIM
Price
$33.80
$1.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
2
Target Price
$43.40
$7.00
AVG Volume (30 Days)
139.2K
1.2M
Earning Date
11-10-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$37,191,000.00
$129,873,000.00
Revenue This Year
$33.33
$101.67
Revenue Next Year
N/A
$10.87
P/E Ratio
N/A
N/A
Revenue Growth
31.30
78.61
52 Week Low
$7.75
$1.25
52 Week High
$39.71
$5.92

Technical Indicators

Market Signals
Indicator
ASMB
STIM
Relative Strength Index (RSI) 48.81 42.16
Support Level $31.51 $1.36
Resistance Level $38.99 $1.64
Average True Range (ATR) 2.15 0.16
MACD -0.32 0.04
Stochastic Oscillator 33.29 29.52

Price Performance

Historical Comparison
ASMB
STIM

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

Share on Social Networks: